PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40123C00183Perform a targeted REVIEW of literature — Duke University

Duke University holds $183.3M across 191 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: Unrestricted. PoP ended Sep 29, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs
Awarding office
Duke University
Recipient
Sep 29, 2026
PoP end
$749K
Obligated
$749K
Potential
541990
NAICS
AN41
PSC
Unrestricted
Set-aside
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Unrestricted
Contract number75F40123C00183
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentDuke University
CAGE4B478
UEITP7EK8DZV6N5
NAICS541990

No full NAICS 541990 intel page yet. Browse NAICS intelligence

PSCAN41
Place of performanceSILVER SPRING MD
Pricing typeCost No Fee
Extent competedFull And Open Competition
PoP startSep 26, 2023
PoP end (current)Sep 29, 2026
Obligated$749K
Current value$749K
Potential value$749K

TO PERFORM A TARGETED REVIEW OF LITERATURE REGARDING QUALITY OF LIFE OF PATIENTS WITH OAB AND THE USE OF LURN SI-10 MEASURE AND TO ELICIT THE RELATIVE IMPORTANCE OF LURN SI-10 ITEMS FROM THE PATIENTS? PERSPECTIVE USING A PREFERENCE-ELICITATION INSTR is a federal Unrestricted award for Fda Office Of Acq Grant Svcs held by Duke University. Estimated value $749K ($749K obligated). Current period of performance ends Sep 29, 2026. Last award drew 1 bidder. Place of performance: SILVER SPRING MD.

TO PERFORM A TARGETED REVIEW OF LITERATURE REGARDING QUALITY OF LIFE OF PATIENTS WITH OAB AND THE USE OF LURN SI-10 MEASURE AND TO ELICIT THE RELATIVE IMPORTANCE OF LURN SI-10 ITEMS FROM THE PATIENTS? PERSPECTIVE USING A PREFERENCE-ELICITATION INSTR

Recompete timing

Public
● Past PoP end (1 days ago)

Current PoP ended Sep 29, 2026 (1 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 75F40123C00183? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Duke University — $183.3M obligated across 191 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($183.3M) · all agencies
Department of Health and Human Services (HHS)$172.3M · 94%Department of Defense (DOD)$4.6M · 3%Department of the Interior (DOI)$3.9M · 2%Department of Veterans Affairs (VA)$1.4M · 1%
Open full company profile →

Related awards

Same incumbent
W81XWH22C0123
RESEARCH AND DEVELOPMENT TBI AND PSYCHOLOGICAL HEALTH RESEARCH PROGRAM PROPOSAL TP210599
$3.0M
Dec 28, 2026
80NSSC26P0252
DECOMPRESSION SICKNESS TESTING - SAT
$350K
Feb 17, 2027
75N93024C00005
PROMOTING T CELL RECOVERY AFTER RADIATION INJURY WITH LONG-ACTING INTERLEUKIN 7
$4.0M
Feb 28, 2027
36C24626P0484
MASS SPECTROMETRY ASSESSMENT OF TARGETED METABOLOMIC AND PROTEOMIC SERVICES
$289K
Apr 9, 2027
36C24E22C0022
MRI SERVICES
$342K
Jun 16, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75F40123C00183?

75F40123C00183 (Perform a targeted REVIEW of literature) is a Fda Office Of Acq Grant Svcs award with a potential value of $749K, currently held by Duke University. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40123C00183?

Fda Office Of Acq Grant Svcs awarded 75F40123C00183 to Duke University (potential $749K).

Who is the incumbent on 75F40123C00183?

Duke University is the incumbent with $183.3M across 191 related awards in SCOUT’s public footprint. The current period of performance ends Sep 29, 2026.

When does Duke University’s 75F40123C00183 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 29, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40123C00183? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40123C00183